NCT05600738

Brief Summary

The purpose of this study is to map the acute, short-term cortical evoked responses to thalamic electrical stimulation in persons with intractable epilepsy

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
20mo left

Started Aug 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress69%
Aug 2022Dec 2027

Study Start

First participant enrolled

August 26, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 25, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 31, 2022

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

October 31, 2022

Status Verified

October 1, 2022

Enrollment Period

4.9 years

First QC Date

October 25, 2022

Last Update Submit

October 25, 2022

Conditions

Keywords

Deep brain stimulation (DBS)neuromodulation therapyResponsive Neurostimulation (RNS)

Outcome Measures

Primary Outcomes (4)

  • Change in amplitude of evoked potentials metrics as assessed by the scalp EEG

    Baseline, Intra intervention (about 20 minutes after baseline)

  • Change in amplitude of evoked potentials metrics as assessed by the scalp EEG

    Baseline, post intervention (about 2 hours after baseline )

  • Change in latencies of evoked potentials and phase synchronization metrics recorded as assessed by the scalp EEG

    Baseline, Intra intervention (about 20 minutes after baseline)

  • Change in latencies of evoked potentials and phase synchronization metrics recorded as assessed by the scalp EEG

    Baseline, post intervention (about 2 hours after baseline )

Secondary Outcomes (2)

  • Change in reaction time to visual stimuli measured as vigilance score assessed by the Psychomotor Vigilance test (PVT)

    Baseline, Intra intervention (about 20 minutes after baseline)

  • Change in reaction time to visual stimuli measured as vigilance score assessed by the Psychomotor Vigilance test (PVT)

    Baseline, post intervention (about 2 hours after baseline)

Study Arms (1)

Treatment

EXPERIMENTAL
Device: RNS/DBS activation

Interventions

This will be performed to study the EEG responses to DBS/RNS stimulation electrical pulses. The stimulation frequencies will be sequentially increased and each stimulation will last for 2 minutes.There will be a 1-2 minute wash out period after each trial.

Treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of Epilepsy
  • undergoing neuromodulation therapy with clinically implanted neuromodulation devices (DBS, RNS)
  • followed in the outpatient epilepsy clinic

You may not qualify if:

  • pregnant women
  • active psychosis, major depression, or suicidal ideation in the preceding year
  • Intelligence quotient (IQ) less than 70 as measured by clinical neuropsychological evaluation
  • Do not agree to share their medical records for research purposes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

RECRUITING

MeSH Terms

Conditions

Drug Resistant Epilepsy

Condition Hierarchy (Ancestors)

EpilepsyBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Sandipan Pati, MD

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 25, 2022

First Posted

October 31, 2022

Study Start

August 26, 2022

Primary Completion (Estimated)

July 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

October 31, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations